HPV associated diseases and women's quality of life

HPV associated diseases and women's quality of life

Human papillomavirus is likely the most common sexually transmitted viral infection worldwide. HPV provokes anogenital diseases and genital warts. It should be noted the specific importance of the quality of life assessment of the women with human papillomavirus - associated cervical diseases.

Bibliographic Details
Main Authors:	E G Sycheva, N M Nazarova, V N Prilepskaya, O V Bourmenskaya, V E Frankevich
Format:	Article
Language:	Russian
Published:	IP Berlin A.V. 2016-08-01
Series:	Гинекология
Subjects:	human papillomavirus cervical intraepithelial neoplasia cervical cancer quality of life
Online Access:	https://gynecology.orscience.ru/2079-5831/article/viewFile/28549/pdf

Similar Items

HPV-associated cervical diseases: screening, methods of examination, principles of treatment
by: Vera N Prilepskaya
Published: (2019-06-01)

Human papillomavirus infection – new perspectives on diagnosis and treatment (review)
by: N V Bestaeva, et al.
Published: (2013-06-01)

Shotgun Lipidomics for Differential Diagnosis of HPV-Associated Cervix Transformation
by: Natalia L. Starodubtseva, et al.
Published: (2022-05-01)

New features in the diagnosis of "lesser" abnormalities of cervical epithelium associated with HPV infection (review of literature)
by: N M Nazarova, et al.
Published: (2015-10-01)

The occurrence of human papillomavirus types in the formation of neoplastic transformation of the epithelium of the cervix in “lesser abnormalies”
by: Elena G. Sycheva, et al.
Published: (2020-05-01)

HPV-associated diseases in women and men: principles for diagnosis, treatment, prevention
by: N. M. Nazarova, et al.
Published: (2019-04-01)

Anogenital diseases associated with HPV infection
by: V N Prilepskaya, et al.
Published: (2015-02-01)

Classical Article Evaluation of health-related quality of life the women with human papillomavirus-associated lesions of the cervical epithelium
by: E G Sycheva, et al.
Published: (2018-10-01)

Diagnostic markers of human papillomavirus persistence and progression of cervical intraepithelial neoplasia
by: O. V. Khoperskaya, et al.
Published: (2022-01-01)

Prophylactic HPV vaccines
by: Mandić Aljoša
Published: (2009-01-01)

Results of the study of HPV-typing of anogenital area in patients with cervical intraepithelial neoplasia
by: L A Sulamanidze, et al.
Published: (2016-02-01)

Changes in HPV16/18 Prevalence among Unvaccinated Women with Cervical Intraepithelial Neoplasia in Japan: Assessment of Herd Effects following the HPV Vaccination Program
by: Mamiko Onuki, et al.
Published: (2022-01-01)

Natural History of Anal HPV Infection in Women Treated for Cervical Intraepithelial Neoplasia
by: Marta del Pino, et al.
Published: (2023-02-01)

CERVICAL SQUAMOUS EPITHELIUM LESIONS ASSOCIATED WITH HUMAN PAPILLOMAVIRUS INFECTION
by: V. A. Еrshov, et al.
Published: (2014-07-01)

The Human Papillomavirus Infection Characteristics for Patients with Cervical Intraepithelial Neoplasia in Yunnan, China: A Sampling Survey Analysis
by: Zhi HF, et al.
Published: (2022-06-01)

Distribution of HPV genotypes in cervical intraepithelial lesions and cervical cancer in Tanzanian women
by: Vidal Adriana C, et al.
Published: (2011-11-01)

Age-related Features of the Cytological Diagnosis of Cervical Dysplasia of Different Degrees
by: Maria Kirillina, et al.
Published: (2019-12-01)

Clinical characteristics, HPV involvement, and demographic risk factors in women with cervical intraepithelial neoplasia complicated by vaginal intraepithelial neoplasia
by: Mindan Xu, et al.
Published: (2024-04-01)

Vulvovaginitis and their correction in patients with cervical HPV-associated diseases in the light of the doctrine of pathomorphosis
by: Irina N. Kononova, et al.
Published: (2021-05-01)

HPV-associated cervicitis
by: Margarita V. Andreeva, et al.
Published: (2023-01-01)

Adjuvant HPV Vaccination to Prevent Recurrent Cervical Dysplasia after Surgical Treatment: A Meta-Analysis
by: Violante Di Donato, et al.
Published: (2021-04-01)

Human papillomavirus-associated anal and cervical neoplasia: evaluation of vaccino-prophylaxis programs
by: N. M. Nazarova, et al.
Published: (2018-04-01)

Women with a positive high-risk human papillomavirus (HPV) test remain at increased risk of HPV infection and cervical precancer ≥15 years later
by: Federica Inturrisi, et al.
Published: (2022-12-01)

Clinical Significance of an HPV DNA Chip Test with Emphasis on HPV-16 and/or HPV-18 Detection in Korean Gynecological Patients
by: Min-Kyung Yeo, et al.
Published: (2016-07-01)

Personalized tactics in cervical intraepithelial neoplasia of the cervix of varying severity
by: Tatyana Yu. Pestrikova, et al.
Published: (2022-04-01)

Topical imiquimod treatment for human papillomavirus infection in patients with and without cervical/vaginal intraepithelial neoplasia
by: Cheng-Tao Lin, et al.
Published: (2012-12-01)

Papillomavirus in cervicovaginal smears of women infected with human immunodefficiency virus
by: Edenilson Eduardo Galore, et al.

Risk Analysis Stratification of CIN 2+ Development in a Cohort of Women Living with HIV with Negative Pap Smear and HR-HPV Test during a Long-Term Follow-Up
by: Barbara Gardella, et al.
Published: (2023-01-01)

HPV Vaccination: The Position Paper of the Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV)
by: Andrea Ciavattini, et al.
Published: (2020-07-01)

Micronutrients and prevention of cervical pre-cancer in HPV vaccinated women: a cross-sectional study
by: Chandrika J Piyathilake, et al.
Published: (2023-02-01)

Significance of the viral load of high-risk HPV in the diagnosis and prediction of cervical lesions: a retrospective study
by: Yang Liu, et al.
Published: (2021-10-01)

Cervical Intraepithelial Neoplasia Grade 3 in a HPV-Vaccinated Patient: A Case Report
by: Mateja Sladič, et al.
Published: (2022-02-01)

Expression of Steroid Hormone Receptors of the Cervix in Cervical Intraepithelial Neoplasia Associated with Human Papillomavirus Infection in Infertile Women
by: E.O. Kindrativ
Published: (2014-11-01)

Human papillomavirus genotype distribution and socio-behavioural characteristics in women with cervical pre-cancer and cancer at the start of a human papillomavirus vaccination programme: the CIN3+ plus study
by: Dianne Egli-Gany, et al.
Published: (2019-01-01)

HPV-16 E7-Specific Cellular Immune Response in Women With Cervical Intraepithelial Lesion Contributes to Viral Clearance: A Cross-Sectional and Longitudinal Clinical Study
by: Lina Zhang, et al.
Published: (2022-01-01)

Human papillomavirus types in cervical high‐grade lesions or cancer among Nordic women—Potential for prevention
by: Cecilie Dovey de la Cour, et al.
Published: (2019-02-01)

The role of human papillomavirus (HPV) testing in the follow-up of patients after treatment for cervical intraepithelial neoplasia (CIN)
by: Goran Dimitrov, et al.
Published: (2013-09-01)

The role of human papillomavirus (HPV) testing in the follow-up of patients after treatment for cervical intraepithelial neoplasia (CIN)
by: Goran Dimitrov, et al.
Published: (2013-09-01)

The Prevalence of Human Papillomavirus Genotypes in Women with Abnormal Cervical Cytology
by: Serap Özen, et al.
Published: (2018-12-01)

Human papillomavirus infection and cervical intraepithelial neoplasia progression are associated with increased vaginal microbiome diversity in a Chinese cohort
by: Yulian Chen, et al.
Published: (2020-08-01)